Drug intelligence / Profile preview

nifuratel + nystatin

Development stage
Unknown
Lead developer
Polichem
Modality
Small Molecules
Administration
Topical, Vaginal
01

Overview

Nifuratel + nystatin is a fixed-dose combination antimicrobial therapy primarily used for the treatment of vulvovaginal infections, including vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis. Nifuratel is a nitrofuran derivative that exhibits potent antiprotozoal and antibacterial activity while also possessing some antifungal properties; it acts by interfering with various enzymatic processes in the target microorganisms and damaging microbial DNA through reactive intermediates. Nystatin is a polyene antifungal that works by binding to ergosterol in the fungal cell membrane, leading to the formation of transmembrane pores, leakage of essential intracellular components, and subsequent cell death. This combination is particularly effective for mixed infections where multiple pathogens are present and is valued for its ability to treat infections without significantly disrupting the protective vaginal Lactobacillus flora.

Brand names
麦咪康帕
Other names
nifuratel-nystatin
02

Targets

ErgosterolNeuraminidase

Beyond the preview

Go deeper on nifuratel + nystatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nifuratel + nystatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call